Frauenklinik

Jahr 2019

Huober J, Schneeweiss A, Blohmer JU, Denkert C, Tesch H, Hanusch CA, Salat C, Rhiem K, Rezai M, Solbach C, Fasching PA, Jackisch C, Mehta K, Nekljudova V, Seither F, von Minckwitz G, Loibl S, Untch M: Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy - Results of a pooled analysis based on the GBG meta-database 2019
Fasching PA, Gass P, Häberle L, Volz B, Hein A, Hack CC, Lux MP, Jud SM, Hartmann A, Beckmann MW, Slamon DJ, Erber R: Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer. 2019
Fasching PA, Huang M, Cortes J, Zhao J, O'Shaughnessy J, Hu P, Haiderali A, Karantza V, Aktan G, Briggs A, Ramsey S, Qi CZ, Xie J, Gu C, Qian K, Yuan M, Wu EQ: Meta-analysis on association of pathological complete response with long-term survival outcomes in triple-negative breast cancer 2019
Pretscher J, Weiss C, Dammer U, Stumpfe F, Faschingbauer F, Beckmann MW, Kehl S: [Induction of Labour in Nulliparous Women Beyond Term in a Low-Risk Population]. 2019
Fasching PA, Jackisch C, Rhiem K, Schneeweiss A, Klare P, Hanusch C, Huober JB, Link T, Untch M, Schmatloch S, Denkert C, Stefek A, Uleer C, Doering G, Engels K, Seither F, Blohmer JU, Loibl S: GeparOLA: A randomized phase II trial to assess the efficacy of paclitaxel and olaparib in comparison to paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant chemotherapy in patients (pts) with HER2-negative early breast cancer (B 2019
Schrauder MG, Brunel-Geuder L, Haeberle L, Wunderle M, Hoyer J, Csorba R, Reis A, Schulz-Wendtland R, Beckmann MW, Lux MP: Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy 2019
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandiño G, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder SJ, Risch H, Chenevix-Trench G, Ramus SJ, Phelan CM, Coetzee GA, Noushmehr H, Hughes TR, Sellers TA, Goode EL, Pharoah PD, Gayther SA, Monteiro ANA, Chen YA, Fridley BL, Aben KKH, Kiemeney LA, Anton-Culver H, Ziogas A, Bruinsma F, Milne RL, Bandera EV, Giles GG, Bean YT, Pejovic T, Beckmann MW, Hein A, Bjorge L, Fasching PA, Thomsen LCV, Kopperud RK, Bischof K, Bogdanova N, Doek T, Hillemanns P, Brinton LA, Wentzensen N, Yang H, Brooks-Wilson A, Bunker CH, Butzow R, Nevanlinna H, Pelttari LM, Campbell IG, Southey MC, Modugno F, Carty K, Glasspool R, McNeish I, Paul J, Siddiqui N, Chang-Claude J, Rudolph A, Chang-Claude J, Cook LS, Cramer DW, Terry KL, Cunningham JM, Cybulski C, Gronwald J, Jakubowska A, Lubinski J, Dansonka-Mieszkowska A, Kupryjanczyk J, Rzepecka IK, du Bois A, Harter P, Dicks E, Song HL, Doherty JA, Rossing MA, Duerst M, Easton DF, Eccles DM, Edwards RP, Ekici AB, Fasching PA, Gao YT, Milne RL, Gentry-Maharaj A, Giles GG, Goodman MT, Thompson PJ, Hasmad HN, Teo SH, Hildebrandt MAT, Wu XF, Hogdall E, Jensen A, Kjaer SK, Hogdall E, Iversen ES, Karlan BY, Lester J, Orsulic S, Walsh CS, Kelley JL, Lambrechts D, Lambrechts S, Vergote I, Lee AW, Levine DA, Liang D, Lissowska J, Lu K, Lundvall L, Kjaer SK, Massuger LFAG, van Altena AM, Matsuo K, McGuire V, McLaughlin JR, Menon U, Moysich KB, Ness RB, Odunsi K, Olson SH, Orlow I, Pike MC, Pearce CL, Wu AH, Permuth JB, Tsai YY, Tworoger SS, Poole EM, Rosen B, Shu XO, Shvetsov YB, Wilkens LR, Sieh W, Spiewankiewicz B, Sucheston-Campbell L, Thomsen L, Wang-Gohrke S, Whittemore AS, Woo YL, Zheng W, Berchuck A, Chenevix-Trench G, Schildkraut JM, Kelemen LE, Freedman ML, Ovarian Canc Asso Consortium AOCS Management Grp: Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus 2019
Vasileiou G, Hoyer J, Thiel CT, Schaefer J, Zapke M, Krumbiegel M, Kraus C, Zweier M, Uebe S, Ekici AB, Schneider M, Wiesener M, Rauch A, Faschingbauer F, Reis A, Zweier C, Popp B: Prenatal diagnosis of HNF1B-associated renal cysts: Is there a need to differentiate intragenic variants from 17q12 microdeletion syndrome? 2019
Scharl AJ, Beckmann MW: Berlin, 04.06.2019 Statement of the DGGG on the Health Information/Accompanying Information of the IQWiG "What are the Benefits of Screening for B-Streptococci in Pregnancy?" and "What is the Use of Determining the Rhesus factor before Birth?" 2019
Kengelbach-Weigand A, Lotz L, Schmid R, Lang W, Beckmann MW, Hoffmann I, Horch RE, Renner SP, Dittrich R, Boos AM, Hildebrandt T: Intra- and Postoperative Blood Flow Monitoring in a Sheep Model of Uterus Transplantation. 2019
Janni W, Rack BK, Friedl TW, Mueller V, Lorenz R, Rezai M, Tesch H, Heinrich G, Andergassen U, Harbeck N, Schochter F, De Gregorio A, Tzschaschel M, Huober J, Hepp P, Fehm TN, Schneeweiss A, Lichtenegger W, Blohmer J, Hauner D, Beckmann MW, Haeberle L, Fasching PA, Hauner H: Lifestyle Intervention and Effect on Disease-free Survival in Early Breast Cancer Pts: Interim Analysis from the Randomized SUCCESS C Study 2019
Lux MP, Emons J, Bani MR, Wunderle M, Sell C, Preuss C, Rauh C, Jud SM, Heindl F, Langemann H, Geyer T, Brandl AL, Hack CC, Adler W, Schulz-Wendtland R, Beckmann MW, Fasching PA, Gass P: Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot Study. 2019
Degenhardt T, Fasching PA, Lueftner D, Mueller V, Thomssen C, Schem C, Witzel I, Decker T, Tesch H, Kuemmel S, Uleer C, Wuerstlein R, Riese C, Schinkoethe T, Kates RE, Schumacher J, Harbeck N, Schmidt M: PRECYCLE Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy 2019
Pretscher J, Schwenke E, Baier F, Kehl S, Schneider M, Stumpfe FM, Schmid M, Beckmann MW, Mayr A, Schild R, Faschingbauer F: Can Sonographic Fetal Biometry Predict Adverse Perinatal Outcome? 2019
Fasching PA, Hu CL, Hart S, Hartkopf AD, Taran FA, Janni W, Tesch H, Haeberle L, Ettl J, Overkamp F, Lux MP, Luftner D, Wallwiener M, Mueller V, Kolberg HC, Fehm TN, Wallwiener D, Brucker S, Schneeweiss A, Couch F: Germline BRCA1 and BRCA2 mutations in patients with HER2-negative metastatic breast cancer (mBC) treated with first-line chemotherapy: Data from the German PRAEGNANT registry. 2019
Trapp E, Janni W, Schindlbeck C, Jückstock J, Andergassen U, deGregorio A, Alunni-Fabbroni M, Tzschaschel M, Polasik A, Koch JG, Friedl TWP, Fasching PA, Haeberle L, Fehm T, Schneeweiss A, Beckmann MW, Pantel K, Mueller V, Rack B, Scholz C: Response to Di Cosimo, Torri, and Porcu. 2019
Ott OJ, Strnad V, Sillkrieg W, Uter W, Beckmann MW, Fietkau R: Accelerated partial breast irradiation with external beam radiotherapy: results of the German phase 2-trial 2019
Hartkopf AD, Müller V, Wöckel A, Lux MP, Janni W, Nabieva N, Taran FA, Ettl J, Lüftner D, Belleville E, Schütz F, Fasching PA, Fehm TN, Kolberg HC, Overkamp F, Schneeweiss A, Tesch H: Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer. 2019
Seelbach-Goebel B, Beckmann MW: Berlin, 12.06.2018. 281 Opinion of the German Society for Gynecology and Obstetrics (DGGG) on substitution-based Treatment of Opiate Addicts 2019
Kengelbach-Weigand A, Tasbihi K, Strissel PL, Schmid R, Marques JM, Beier JP, Beckmann MW, Strick R, Horch RE, Boos AM: Plasticity of patient-matched normal mammary epithelial cells is dependent on autologous adipose-derived stem cells. 2019
Krause S, Friedl T, Fehm T, Romashova T, Fasching PA, Schneeweiss A, Mueller V, Taran FA, Polasik A, Tzschaschel M, De Gregorio A, Meier-Stiegen F, Janni W, Huober J: DETECT V/CHEVENDO - Comparison of dual HER2-targeted therapy with trastuzumab plus pertuzumab in combination with chemo- or endocrine therapy in addition with CDK4/6 inhibition in patients with HER2-positive and hormone-receptor positive metastatic breast cancer 2019
Wachter DL, Wachter PW, Fasching PA, Beckmann MW, Hack CC, Riener MO, Hartmann A, Strehl JD: Characterization of Molecular Subtypes of Paget Disease of the Breast Using Immunohistochemistry and In Situ Hybridization. 2019
Schmid P, Cortes J, Dent R, Pusztai L, McArthur HL, Kuemmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Jia L, Karantza V, Zhao J, Aktan G, O'Shaughnessy J: KEYNOTE-522: Phase III study of pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC) 2019
Hammersen J, Wohlfart S, Goecke TW, Köninger A, Stepan H, Gallinat R, Morris S, Bücher K, Clarke A, Wünsche S, Beckmann MW, Schneider H, Faschingbauer F: Reliability of prenatal detection of X-linked hypohidrotic ectodermal dysplasia by tooth germ sonography. 2019
Hurvitz SA, Martin M, Jung KH, Huang CS, Harbeck N, Valero V, Stroyakovskiy D, Wildiers H, Campone M, Boileau JF, Beckmann MW, Afenjar K, Spera G, Valverde VL, Song C, Boulet T, Sparano JA, Symmans WF, Thompson AM, Slamon DJ: Neoadjuvant trastuzumab (H), pertuzumab (P), and chemotherapy versus trastuzumab emtansine (T-DM1) and P in human epidermal growth factor receptor 2 (H ER2)-positive breast cancer (BC): Final outcome results from the phase III KRISTINE study. 2019
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, Aldrich MC, Andrew AS, Andrulis IL, Anton-Culver H, Antoniou AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Batra J, Beckmann MW, Benitez J, Benlloch S, Berchuck A, Berndt SI, Bickeböller H, Bien SA, Blomqvist C, Boccia S, Bogdanova NV, Bojesen SE, Bolla MK, Brauch H, Brenner H, Brenton JD, Brook MN, Brunet J, Brunnström H, Buchanan DD, Burwinkel B, Butzow R, Cadoni G, Caldes T, Caligo MA, Campbell I, Campbell PT, Cancel-Tassin G, Cannon-Albright L, Campa D, Caporaso N, Carvalho AL, Chan AT, Chang-Claude J, Chanock SJ, Chen C, Christiani DC, Claes KBM, Claessens F, Clements J, Collée JM, Correa MC, Couch FJ, Cox A, Cunningham JM, Cybulski C, Czene K, Daly MB, deFazio A, Devilee P, Diez O, Gago-Dominguez M, Donovan JL, Dörk T, Duell EJ, Dunning AM, Dwek M, Eccles DM, Edlund CK, Edwards DRV, Ellberg C, Evans DG, Fasching PA, Ferris RL, Liloglou T, Figueiredo JC, Fletcher O, Fortner RT, Fostira F, Franceschi S, Friedman E, Gallinger SJ, Ganz PA, Garber J, García-Sáenz JA, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, Goode EL, Goodman MT, Goodman G, Grankvist K, Greene MH, Gronberg H, Gronwald J, Guénel P, Håkansson N, Hall P, Hamann U, Hamdy FC, Hamilton RJ, Hampe J, Haugen A, Heitz F, Herrero R, Hillemanns P, Hoffmeister M, Høgdall E, Hong YC, Hopper JL, Houlston R, Hulick PJ, Hunter DJ, Huntsman DG, Idos G, Imyanitov EN, Ingles SA, Isaacs C, Jakubowska A, James P, Jenkins MA, Johansson M, Johansson M, John EM, Joshi AD, Kaneva R, Karlan BY, Kelemen LE, Kühl T, Khaw KT, Khusnutdinova E, Kibel AS, Kiemeney LA, Kim J, Kjaer SK, Knight JA, Kogevinas M, Kote-Jarai Z, Koutros S, Kristensen VN, Kupryjanczyk J, Lacko M, Lam S, Lambrechts D, Landi MT, Lazarus P, Le ND, Lee E, Lejbkowicz F, Lenz HJ, Leslie G, Lessel D, Lester J, Levine DA, Li L, Li CI, Lindblom A, Lindor NM, Liu G, Loupakis F, Lubi?ski J, Maehle L, Maier C, Mannermaa A, Marchand LL, Margolin S, May T, McGuffog L, Meindl A, Middha P, Miller A, Milne RL, MacInnis RJ, Modugno F, Montagna M, Moreno V, Moysich KB, Mucci L, Muir K, Mulligan AM, Nathanson KL, Neal DE, Ness AR, Neuhausen SL, Nevanlinna H, Newcomb PA, Newcomb LF, Nielsen FC, Nikitina-Zake L, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olama AAA, Olopade OI, Olshan AF, Olsson H, Osorio A, Pandha H, Park JY, Pashayan N, Parsons MT, Pejovic T, Penney KL, Peters WHM, Phelan CM, Phipps AI, Plaseska-Karanfilska D, Pring M, Prokofyeva D, Radice P, Stefansson K, Ramus SJ, Raskin L, Rennert G, Rennert HS, van Rensburg EJ, Riggan MJ, Risch HA, Risch A, Roobol MJ, Rosenstein BS, Rossing MA, De Ruyck K, Saloustros E, Sandler DP, Sawyer EJ, Schabath MB, Schleutker J, Schmidt MK, Setiawan VW, Shen H, Siegel EM, Sieh W, Singer CF, Slattery ML, Sorensen KD, Southey MC, Spurdle AB, Stanford JL, Stevens VL, Stintzing S, Stone J, Sundfeldt K, Sutphen R, Swerdlow AJ, Tajara EH, Tangen CM, Tardón A, Taylor JA, Teare MD, Teixeira MR, Terry MB, Terry KL, Thibodeau SN, Thomassen M, Bjørge L, Tischkowitz M, Toland AE, Torres D, Townsend PA, Travis RC, Tung N, Tworoger SS, Ulrich CM, Usmani N, Vachon CM, Van Nieuwenhuysen E, Vega A, Aguado-Barrera ME, Wang Q, Webb PM, Weinberg CR, Weinstein S, Weissler MC, Weitzel JN, West CML, White E, Whittemore AS, Wichmann HE, Wiklund F, Winqvist R, Wolk A, Woll P, Woods M, Wu AH, Wu X, Yannoukakos D, Zheng W, Zienolddiny S, Ziogas A, Zorn KK, Lane JM, Saxena R, Thomas D, Hung RJ, Diergaarde B, McKay J, Peters U, Hsu L, García-Closas M, Eeles RA, Chenevix-Trench G, Brennan PJ, Haiman CA, Simard J, Easton DF, Gruber SB, Pharoah PDP, Price AL, Pasaniuc B, Amos CI, Kraft P, Lindström S: Shared heritability and functional enrichment across six solid cancers. 2019
Heil J, Riedel F, Solbach C, Gerber B, Marx M, Brucker S, Heitmann C, Hoffmann J, Wallwiener M, Lux MP, Wallwiener D, Hahn M: Oncoplastic breast-conserving surgery: More relevant than ever? Results of a survey among breast surgeons. 2019
Janni W, Schneeweiss A, Müller V, Wöckel A, Lux MP, Hartkopf AD, Nabieva N, Taran FA, Tesch H, Overkamp F, Lüftner D, Belleville E, Schütz F, Fasching PA, Fehm TN, Kolberg HC, Ettl J: Update Breast Cancer 2019 Part 2 - Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice. 2019
Scharl AJ, Beckmann MW: Berlin, 30.01.2019 Statement of the DGGG on the IQWiG-Commission HT17-02 preliminary Basic Report on the HTA Report "Cancer: Can a concomitant Music Therapy contribute to better Treatment Results?" 2019
Beckmann MW: Dear Readers 2019
Marme F, Solbach C, Michel L, Fasching PA, Schneeweiss A, Blohmer JU, Rezai M, Huober J, Jackisch C, Nekljudova V, Link T, Rhiem K, Denkert C, Hanusch C, Tesch H, Lederer B, Loibl S, Untch M: Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy 2019
Krause S, Friedl T, Romashova T, Fasching PA, Schneeweiss A, Mueller V, Taran FA, Arkadius P, Marie T, De Gregorio A, Meier-Stiegen F, Huober J, Janni W, Fehm T: DETECT III/IV study trial - The multicenter study program in patients with HER2-negative metastatic breast cancer and circulating tumor cells 2019
Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Boeckx B, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Brenner H, Brentnall A, Brinton L, Broberg P, Brock IW, Brucker SY, Burwinkel B, Caldas C, Caldes T, Campa D, Canzian F, Carracedo A, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Cheng TD, Chin SF, Clarke CL, NBCS Collaborators , Cordina-Duverger E, Couch FJ, Cox DG, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dunn JA, Dunning AM, Durcan L, Dwek M, Earl HM, Ekici AB, Eliassen AH, Ellberg C, Engel C, Eriksson M, Evans DG, Figueroa J, Flesch-Janys D, Flyger H, Gabrielson M, Gago-Dominguez M, Galle E, Gapstur SM, García-Closas M, García-Sáenz JA, Gaudet MM, George A, Georgoulias V, Giles GG, Glendon G, Goldgar DE, González-Neira A, Alnæs GIG, Grip M, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Hankinson S, Harkness EF, Harrington PA, Hart SN, Hartikainen JM, Hein A, Hillemanns P, Hiller L, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huang G, Humphreys K, Hunter DJ, Janni W, John EM, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kabisch M, Kaczmarek K, Kerin MJ, Khan S, Khusnutdinova E, Kiiski JI, Kitahara CM, Knight JA, Ko YD, Koppert LB, Kosma VM, Kraft P, Kristensen VN, Krüger U, Kühl T, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Li L, Lindblom A, Lindström S, Linet M, Lissowska J, Lo WY, Loibl S, Lubi?ski J, Lux MP, MacInnis RJ, Maierthaler M, Maishman T, Makalic E, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Mavroudis D, McLean C, Meindl A, Middha P, Miller N, Milne RL, Moreno F, Mulligan AM, Mulot C, Nassir R, Neuhausen SL, Newman WT, Nielsen SF, Nordestgaard BG, Norman A, Olsson H, Orr N, Pankratz VS, Park-Simon TW, Perez JIA, Pérez-Barrios C, Peterlongo P, Petridis C, Pinchev M, Prajzendanc K, Prentice R, Presneau N, Prokofieva D, Pylkäs K, Rack B, Radice P, Ramachandran D, Rennert G, Rennert HS, Rhenius V, Romero A, Roylance R, Saloustros E, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schwentner L, Scott RJ, Scott C, Seynaeve C, Shah M, Simard J, Smeets A, Sohn C, Southey MC, Swerdlow AJ, Talhouk A, Tamimi RM, Tapper WJ, Teixeira MR, Tengström M, Terry MB, Thöne K, Tollenaar RAEM, Tomlinson I, Torres D, Truong T, Turman C, Turnbull C, Ulmer HU, Untch M, Vachon C, van Asperen CJ, van den Ouweland AMW, van Veen EM, Wendt C, Whittemore AS, Willett W, Winqvist R, Wolk A, Yang XR, Zhang Y, Easton DF, Fasching PA, Nevanlinna H, Eccles DM, Pharoah PDP, Schmidt MK: Genome-wide association study of germline variants and breast cancer-specific mortality. 2019
Slamon DJ, Neven P, Chia S, Fasching PA, De Laurentiis M, Im SA, Petrakova K, Bianchi GV, Esteva FJ, Martin M, Nusch A, Sonke GS, De la Cruz-Merino L, Beck JT, Pivot X, Sondhi M, Wang Y, Chakravartty A, Rodriguez-Lorenc K, Jerusalem G: Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) treated with fulvestrant (FUL) (+) ribociclib (RIB) 2019
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Auer PL, Auvinen P, Barrdahl M, Beane Freeman LE, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Børresen-Dale AL, Brauch H, Bremer M, Brenner H, Brentnall A, Brock IW, Brooks-Wilson A, Brucker SY, Brüning T, Burwinkel B, Campa D, Carter BD, Castelao JE, Chanock SJ, Chlebowski R, Christiansen H, Clarke CL, Collée JM, Cordina-Duverger E, Cornelissen S, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, dos-Santos-Silva I, Dumont M, Durcan L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Engel C, Eriksson M, Evans DG, Fasching PA, Figueroa J, Fletcher O, Flyger H, Försti A, Fritschi L, Gabrielson M, Gago-Dominguez M, Gapstur SM, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Gilyazova IR, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grenaker Alnæs GI, Grip M, Gronwald J, Grundy A, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hamann U, Hankinson SE, Harkness EF, Hart SN, He W, Hein A, Heyworth J, Hillemanns P, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huang G, Humphreys K, Hunter DJ, Jakimovska M, Jakubowska A, Janni W, John EM, Johnson N, Jones ME, Jukkola-Vuorinen A, Jung A, Kaaks R, Kaczmarek K, Kataja V, Keeman R, Kerin MJ, Khusnutdinova E, Kiiski JI, Knight JA, Ko YD, Kosma VM, Koutros S, Kristensen VN, Krüger U, Kühl T, Lambrechts D, Le Marchand L, Lee E, Lejbkowicz F, Lilyquist J, Lindblom A, Lindström S, Lissowska J, Lo WY, Loibl S, Long J, Lubinski J, Lux MP, MacInnis RJ, Maishman T, Makalic E, Maleva Kostovska I, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Martinez ME, Mavroudis D, McLean C, Meindl A, Menon U, Middha P, Miller N, Moreno F, Mulligan AM, Mulot C, Muñoz-Garzon VM, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Nielsen SF, Nordestgaard BG, Norman A, Offit K, Olson JE, Olsson H, Orr N, Pankratz VS, Park-Simon TW, Perez JIA, Pérez-Barrios C, Peterlongo P, Peto J, Pinchev M, Plaseska-Karanfilska D, Polley EC, Prentice R, Presneau N, Prokofyeva D, Purrington K, Pylkäs K, Rack B, Radice P, Rau-Murthy R, Rennert G, Rennert HS, Rhenius V, Robson M, Romero A, Ruddy KJ, Ruebner M, Saloustros E, Sandler DP, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schürmann P, Schwentner L, Scott C, Scott RJ, Seynaeve C, Shah M, Sherman ME, Shrubsole MJ, Shu XO, Slager S, Smeets A, Sohn C, Soucy P, Southey MC, Spinelli JJ, Stegmaier C, Stone J, Swerdlow AJ, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Thöne K, Tollenaar RAEM, Tomlinson I, Truong T, Tzardi M, Ulmer HU, Untch M, Vachon CM, van Veen EM, Vijai J, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett W, Winqvist R, Wolk A, Yang XR, Yannoukakos D, Zhang Y, Zheng W, Ziogas A, ABCTB Investigators , kConFab/AOCS Investigators , NBCS Collaborators , Dunning AM, Thompson DJ, Chenevix-Trench G, Chang-Claude J, Schmidt MK, Hall P, Milne RL, Pharoah PDP, Antoniou AC, Chatterjee N, Kraft P, García-Closas M, Simard J, Easton DF: Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. 2019
Loibl S, Sinn BV, Karn T, Untch M, Sinn HP, Weber KE, Hanusch C, Huober JB, Staib P, Lorenz R, Blohmer JU, Marme F, Schmitt WD, Rhiem K, van Mackelenbergh M, Fasching PA, Wu S, Higgs BW, Schneeweiss A, Denkert C: Exome analysis of oncogenic pathways and tumor mutational burden (TMB) in triple-negative breast cancer (TNBC): Results of the translational biomarker program of the neoadjuvant double-blind placebo controlled GeparNuevo trial. 2019
Konecny GE, Fasching PA: Editorial: The potential for precision medicine to improve care and speed the development of new treatments in breast and gynecologic malignancies. 2019
Ranjbaran A, Nejabati HR, Ghasemnejad T, Latifi Z, Hamdi K, Hajipour H, Raffel N, Bahrami-Asl Z, Hakimi P, Mihanfar A, Nouri M, Fattahi A: Follicular Fluid Levels of Adrenomedullin 2, Vascular Endothelial Growth Factor and its Soluble Receptors Are Associated with Ovarian Response During ART Cycles. 2019
Kolberg HC, Schneeweiss A, Fehm TN, Wöckel A, Huober J, Pontones C, Titzmann A, Belleville E, Lux MP, Janni W, Hartkopf AD, Taran FA, Wallwiener M, Overkamp F, Tesch H, Ettl J, Lüftner D, Müller V, Schütz F, Fasching PA, Brucker SY: Update Breast Cancer 2019 Part 3 - Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel. 2019
Scharl AJ, Beckmann MW: Berlin, 19.02.2019 278th Statement of the German Society for Gynecology and Obstetrics (DGGG) on Abemaciclib (Breast Cancer, Combination with Fulvestrant) - Benefit Assessment according to 35a SGB V 2019
Tesch H, Loibl S, Kast K, Jackisch C, Mobus V, Buchen S, Untch M, Hanusch C, Seiler S, Weigel M, Fasching PA, Rhiem K, Huober J, Blohmer JU, Solbach C, Denkert C, Nekljudova V, Link T, Schneeweiss A: Chemotherapy (CT)-induced anaemia in patients (pts) treated with dose-dense regimen: Results of the prospectively randomised anaemia substudy from the neoadjuvant GeparOcto study 2019
Loibl S, Sinn BV, Karn T, Untch M, Treue D, Sinn HP, Weber KE, Hanusch CA, Fasching PA, Huober J, Zahm DM, Jackisch C, Thomalla J, Blohmer JU, Marme F, Klauschen F, Rhiem K, Felder B, von Minckwitz G, Burchardi N, Schneeweiss A, Denkert C: mRNA signatures predict response to durvalumab therapy in triple negative breast cancer (TNBC) Results of the translational biomarker programme of the neoadjuvant double-blind placebo controlled GeparNuevo trial 2019
Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, Kiiski JI, Muranen TA, Barnes DR, Dennis J, Michailidou K, Bolla MK, Leslie G, Aalfs CM, ABCTB Investigators , Adank MA, Adlard J, Agata S, Cadoo K, Agnarsson BA, Ahearn T, Aittomäki K, Ambrosone CB, Andrews L, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, Aronson KJ, Arun BK, Asseryanis E, Auber B, Auvinen P, Azzollini J, Balmana J, Barkardottir RB, Barrowdale D, Barwell J, Beane Freeman LE, Beauparlant CJ, Beckmann MW, Behrens S, Benitez J, Berger R, Bermisheva M, Blanco AM, Blomqvist C, Bogdanova NV, Bojesen A, Bojesen SE, Bonanni B, Borg A, Brady AF, Brauch H, Brenner H, Brüning T, Burwinkel B, Buys SS, Caldes T, Caliebe A, Caligo MA, Campa D, Campbell IG, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Claes KBM, Clarke CL, Collavoli A, Conner TA, Cox DG, Cybulski C, Czene K, Daly MB, de la Hoya M, Devilee P, Diez O, Ding YC, Dite GS, Ditsch N, Domchek SM, Dorfling CM, dos-Santos-Silva I, Durda K, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Eriksson M, Evans DG, Fasching PA, Figueroa J, Flyger H, Foulkes WD, Friebel TM, Friedman E, Gabrielson M, Gaddam P, Gago-Dominguez M, Gao C, Gapstur SM, Garber J, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, GEMO Study Collaborators , Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, Guénel P, Gutierrez-Barrera AM, Haeberle L, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hein A, Heyworth J, Hillemanns P, Hollestelle A, Hopper JL, Hosgood HD, Howell A, Hu C, Hulick PJ, Hunter DJ, Imyanitov EN, kConFab , Isaacs C, Jakimovska M, Jakubowska A, James P, Janavicius R, Janni W, John EM, Jones ME, Jung A, Kaaks R, Karlan BY, Khusnutdinova E, Kitahara CM, Konstantopoulou I, Koutros S, Kraft P, Lambrechts D, Lazaro C, Le Marchand L, Lester J, Lesueur F, Lilyquist J, Loud JT, Lu KH, Luben RN, Lubinski J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martens JWM, Maurer T, Mavroudis D, Mebirouk N, Meindl A, Menon U, Miller A, Montagna M, Nathanson KL, Neuhausen SL, Newman WG, Nguyen-Dumont T, Nielsen FC, Nielsen S, Nikitina-Zake L, Offit K, Olah E, Olopade OI, Olshan AF, Olson JE, Olsson H, Osorio A, Ottini L, Peissel B, Peixoto A, Peto J, Plaseska-Karanfilska D, Pocza T, Presneau N, Pujana MA, Punie K, Rack B, Rantala J, Rashid MU, Rau-Murthy R, Rennert G, Lejbkowicz F, Rhenius V, Romero A, Rookus MA, Ross EA, Rossing M, Rudaitis V, Ruebner M, Saloustros E, Sanden K, Santamariña M, Scheuner MT, Schmutzler RK, Schneider M, Scott C, Senter L, Shah M, Sharma P, Shu XO, Simard J, Singer CF, Sohn C, Soucy P, Southey MC, Spinelli JJ, Steele L, Stoppa-Lyonnet D, Tapper WJ, Teixeira MR, Terry MB, Thomassen M, Thompson J, Thull DL, Tischkowitz M, Tollenaar RAEM, Torres D, Troester MA, Truong T, Tung N, Untch M, Vachon CM, van Rensburg EJ, van Veen EM, Vega A, Viel A, Wappenschmidt B, Weitzel JN, Wendt C, Wieme G, Wolk A, Yang XR, Zheng W, Ziogas A, Zorn KK, Dunning AM, Lush M, Wang Q, McGuffog L, Parsons MT, Pharoah PDP, Fostira F, Toland AE, Andrulis IL, Ramus SJ, Swerdlow AJ, Greene MH, Chung WK, Milne RL, Chenevix-Trench G, Dörk T, Schmidt MK, Easton DF, Radice P, Hahnen E, Antoniou AC, Couch FJ, Nevanlinna H, Surralles J, Peterlongo P, Balleine R, Baxter R, Braye S, Carpenter J, Dahlstrom J, Forbes J, Lee CS, Marsh D, Morey A, Pathmanathan N, Scott R, Simpson P, Spigelman A, Wilcken N, Yip D, Zeps N, Belotti M, Bertrand O, Birot AM, Buecher B, Caputo S, Dupré A, Fourme E, Gauthier-Villars M, Golmard L, Le Mentec M, Moncoutier V, de Pauw A, Saule C, Boutry-Kryza N, Calender A, Giraud S, Léone M, Bressac-de-Paillerets B, Caron O, Guillaud-Bataille M, Bignon YJ, Uhrhammer N, Bonadona V, Lasset C, Berthet P, Castera L, Vaur D, Bourdon V, Nogues C, Noguchi T, Popovici C, Remenieras A, Sobol H, Coupier I, Pujol P, Adenis C, Dumont A, Révillion F, Muller D, Barouk-Simonet E, Bonnet F, Bubien V, Longy M, Sevenet N, Gladieff L, Guimbaud R, Feillel V, Toulas C, Dreyfus H, Leroux CD, Peysselon M, Rebischung C, Legrand C, Baurand A, Bertolone G, Coron F, Faivre L, Jacquot C, Lizard S, Kientz C, Lebrun M, Prieur F, Fert-Ferrer S, Mari V, Vénat-Bouvet L, Bezieau S, Delnatte C, Mortemousque I, Colas C, Coulet F, Soubrier F, Warcoin M, Bronner M, Sokolowska J, Collonge-Rame MA, Damette A, Gesta P, Lallaoui H, Chiesa J, Molina-Gomes D, Ingster O, Manouvrier-Hanu S, Lejeune S, Aghmesheh M, Greening S, Amor D, Gattas M, Botes L, Buckley M, Friedlander M, Koehler J, Meiser B, Saleh M, Salisbury E, Trainer A, Tucker K, Antill Y, Dobrovic A, Fellows A, Fox S, Harris M, Nightingale S, Phillips K, Sambrook J, Thorne H, Armitage S, Arnold L, Balleine R, Kefford R, Kirk J, Rickard E, Bastick P, Beesley J, Hayward N, Spurdle A, Walker L, Beilby J, Saunders C, Bennett I, Blackburn A, Bogwitz M, Gaff C, Lindeman G, Pachter N, Scott C, Sexton A, Visvader J, Taylor J, Winship I, Brennan M, Brown M, French J, Edwards S, Burgess M, Burke J, Patterson B, Butow P, Culling B, Caldon L, Callen D, Chauhan D, Eisenbruch M, Heiniger L, Chauhan M, Christian A, Dixon J, Kidd A, Cohen P, Colley A, Fenton G, Crook A, Dickson R, Field M, Marsh D, Cui J, Cummings M, Dawson SJ, deFazio A, Delatycki M, Dudding T, Edkins T, Farshid G, Flanagan J, Fong P, Forrest L, Gallego-Ortega D, George P, Gill G, Kollias J, Haan E, Hart S, Jenkins M, Hunt C, Lakhani S, Lipton L, Lobb L, Mann G, McLachlan SA, O'Connell S, O'Sullivan S, Pieper E, Robinson B, Saunus J, Scott E, Scott R, Shelling A, Simpson P, Williams R, Young MA: The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. 2019
Muenzner JK, Ranjan RA, Eckstein M, Erber R, Kunze P, Geppert CI, Ruebner M, Baeuerle T, Hartmann A, Schneider-Stock R: Tumor budding: A predictor for metastasis in the CAM xenograft model 2019
Krebs J, Wasner S, Egloffstein S, Lux MP, Morawa E, Beckmann MW, Erim Y: [Resilience, Fear of Progression and Psychosocial Distress in Patients with Breast Cancer and Gynecological Tumors Seeking a Second Opinion]. 2019
Mayer F, Pleimes D, Schmidt M, Fasching PA, Jackisch C, Flunkert K, Asang C, Razoux F, Moebus V: Investigation of the efficacy of imidazolyl ethanamide pentandioic acid (IEPA) to reduce chemotherapy-induced myelosuppression (CIM) in breast cancer patients. 2019
Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, Furlanetto J, Tesch H, Hanusch C, Engels K, Rezai M, Jackisch C, Schmitt WD, von Minckwitz G, Thomalla J, Kümmel S, Rautenberg B, Fasching PA, Weber K, Rhiem K, Denkert C, Schneeweiss A: A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study. 2019
Schacher NM, Raaz-Schrauder D, Pasutto F, Stumpfe FM, Tauchi M, Dietel B, Achenbach S, Urschel K: Impact of single nucleotide polymorphisms in the VEGFR2 gene on endothelial cell activation under non‑uniform shear stress. 2019
Untch M, Thomssen C, Bauerfeind I, Braun M, Brucker SY, Felberbaum R, Hagemann F, Haidinger R, Hönig A, Huober J, Jackisch C, Kolberg HC, Kolberg-Liedtke C, Kühn T, Lüftner D, Maass N, Reimer T, Schneeweiss A, Schumacher-Wulf E, Schütz F, Thill M, Wuerstlein R, Fasching PA, Harbeck N: Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019). 2019
Scharl AJ, Beckmann MW: 279th Statement of the German Society of Gynecology and Obstetrics (DGGG) on Abemaciclib (Breast Cancer, Combination with an Aromatase Inhibitor) - Benefit Assessment according to 35a SGB V 2019
Scharl AJ, Beckmann MW: 280th Statement of the Committee Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. (DGGG) on the Pharmaceuticals Guidelines Ribociclib 2019
Beckmann MW: Dear Readers 2019
Lux MP, Hartkopf AD, Huober J, Volz B, Taran FA, Overkamp F, Hadji P, Tesch H, Haeberle L, Ettl J, Lueftner DI, Wallwiener M, Mueller V, Beckmann M, Belleville E, Wimberger P, Hielscher C, Geberth M, Lermann J, Abenhardt W, Kurbacher C, Wuerstlein R, Thomssen C, Untch M, Fasching PA, Janni W, Fehm TN, Wallwiener D, Brucker SY, Schneeweiss A, Kolberg HC: Therapy landscape of patients with metastatic, HER2 positive breast cancer - Data from the real world breast cancer registry PRAEGNANT (NCT02338167) 2019
Golub Y, Kuitunen-Paul S, Panaseth K, Stonawski V, Frey S, Steigleder R, Grimm J, Goecke TW, Fasching PA, Beckmann MW, Kornhuber J, Kratz O, Heinrich H, Moll GH, Eichler A: Salivary and hair cortisol as biomarkers of emotional and behavioral symptoms in 6-9 year old children. 2019
Lueftner D, Bauerfeind I, Braun M, Brucker SY, Fasching PA, Felberbaum R, Hagemann F, Haidinger R, Harbeck N, Hoenig A, Huober J, Jackisch C, Kolberg HC, Kolberg-Liedtke C, Kuehn T, Maass N, Reimer T, Schneeweiss A, Schumacher-Wulf E, Schuetz F, Thomssen C, Untch M, Wuerstlein R, Thill M: Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019) 2019
Beckmann MW, Lotz L, Toth B, Baston-Büst DM, Fehm T, Frambach T, Germeyer A, Goeckenjan M, Häberlin F, Henes M, Hirchenhain J, Hübner S, Korell M, Krüssel JS, Müller A, Reinsberg J, Schwab R, Seitz S, Sütterlin M, van der Ven H, van der Ven K, Winkler-Crepaz K, Wimberger P, von Wolff M, Liebenthron J, Dittrich R: Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation. 2019
Nusch A, Decker T, Reinisch M, Hartkopf AD, Heinrich B, Kurbacher CM, Fuchs RD, Tesch H, Krabisch P, Brucker S, Fehm TN, Janni W, Kuemmel S, Luftner D, Schneeweiss A, Schuler MH, Voges C, Schubert J, Fasching PA: RIBECCA: A phase IIIb, multicenter, open label study for women with estrogen receptor-positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole-Results of the second interim analysis. 2019
Giardiello D, Steyerberg EW, Hauptmann M, Adank MA, Akdeniz D, Blomqvist C, Bojesen SE, Bolla MK, Brinkhuis M, Chang-Claude J, Czene K, Devilee P, Dunning AM, Easton DF, Eccles DM, Fasching PA, Figueroa J, Flyger H, García-Closas M, Haeberle L, Haiman CA, Hall P, Hamann U, Hopper JL, Jager A, Jakubowska A, Jung A, Keeman R, Kramer I, Lambrechts D, Le Marchand L, Lindblom A, Lubiński J, Manoochehri M, Mariani L, Nevanlinna H, Oldenburg HSA, Pelders S, Pharoah PDP, Shah M, Siesling S, Smit VTHBM, Southey MC, Tapper WJ, Tollenaar RAEM, van den Broek AJ, van Deurzen CHM, van Leeuwen FE, van Ongeval C, Van't Veer LJ, Wang Q, Wendt C, Westenend PJ, Hooning MJ, Schmidt MK: Prediction and clinical utility of a contralateral breast cancer risk model. 2019
Ranjbaran A, Latifi Z, Nejabati HR, Abroon S, Mihanfar A, Sadigh AR, Fattahi A, Nouri M, Raffel N: Exosome-based intercellular communication in female reproductive microenvironments. 2019
Schneeweiss A, Denkert C, Fasching PA, Fremd C, Gluz O, Kolberg-Liedtke C, Loibl S, Lück HJ: Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) - Recommendations for Daily Routine Practice. 2019
Stumpfe FM, Faschingbauer F, Kehl S, Pretscher J, Stelzl P, Mayr A, Schild RL, Schmid M, Beckmann MW, Schneider MO: Correlation of short-term variation and Doppler parameters with adverse perinatal outcome in small-for-gestational age fetuses at term. 2019
Hildebrandt T, Oversohl N, Dittrich R, Lotz L, Beckmann MW, Lux MP: Can a University Reproductive Medicine Centre Be Financed Under the Pre-Existing General Conditions in Germany? 2019
Scharl AJ, Beckmann MW: Statement of the German Society for Gynecology and Obstetrics (DGGG) on the S18-01 Preliminary Report "Screening for Sickle Cell Disease (SCD) in Newborns" 2019
Beckmann MW: Dear Readers 2019
Massa C, Schneeweiss A, Karn T, Hanusch CA, Blohmer JU, Fasching PA, Jackisch C, van Mackelenbergh M, Marme F, Mueller V, Schem C, Stickeler E, Huober J, Weber KE, Untch M, Denkert C, Loibl S, Mueller A, Biehl K, Seliger B: Immunomonitoring of triple negative breast cancer patients undergoing neoadjuvant therapy with durvalumab - Results from the prospectively randomized GeparNuevo trial 2019
Poehls UG, Hack CC, Wunderle M, Renner SP, Lux MP, Beckmann MW, Fasching PA, Nabieva N: Awareness of breast cancer incidence and risk factors among healthy women in Germany: an update after 10 years. 2019
Eckstein M, Strissel P, Pfannstiel C, Chiappinelli K, Sikic D, Wach S, Taubert H, Wullich B, Keck B, Wirtz R, Breyer J, Burger M, Otto W, Fuhrich N, Geppert C, Weyerer V, Bertz S, Stoehr R, Erlmeier F, Hartmann A, Strick R: Tumour immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes 2019
Papathemelis T, Scharl S, Hipp M, Scharl A, Beckmann MW, Lux MP, Kölbl O: Quality of life and oncological outcome in endometrial cancer patients after vaginal brachytherapy: comparison of two dosing schemes. 2019
Pohl-Rescigno E, Hauke J, Rhiem K, Mobus V, Furlanetto J, Denkert C, Fasching PA, Hanusch C, Tesch H, Weber-Lassalle N, Muller V, Untch M, Luebbe K, Lederer B, Jackisch C, Nekljudova V, Schmutzler RK, Loibl S, Schneeweiss A, Hahnen E: Germline mutation status and therapy response in high-risk early breast cancer: Results of the GeparOcto study (NCT02125344). 2019
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, Aldrich MC, Andrew AS, Andrulis IL, Anton-Culver H, Antoniou AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Batra J, Beckmann MW, Benitez J, Benlloch S, Berchuck A, Berndt SI, Bickeböller H, Bien SA, Blomqvist C, Boccia S, Bogdanova NV, Bojesen SE, Bolla MK, Brauch H, Brenner H, Brenton JD, Brook MN, Brunet J, Brunnström H, Buchanan DD, Burwinkel B, Butzow R, Cadoni G, Caldes T, Caligo MA, Campbell I, Campbell PT, Cancel-Tassin G, Cannon-Albright L, Campa D, Caporaso N, Carvalho AL, Chan AT, Chang-Claude J, Chanock SJ, Chen C, Christiani DC, Claes KBM, Claessens F, Clements J, Collée JM, Correa MC, Couch FJ, Cox A, Cunningham JM, Cybulski C, Czene K, Daly MB, deFazio A, Devilee P, Diez O, Gago-Dominguez M, Donovan JL, Dörk T, Duell EJ, Dunning AM, Dwek M, Eccles DM, Edlund CK, Edwards DRV, Ellberg C, Evans DG, Fasching PA, Ferris RL, Liloglou T, Figueiredo JC, Fletcher O, Fortner RT, Fostira F, Franceschi S, Friedman E, Gallinger SJ, Ganz PA, Garber J, García-Sáenz JA, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, Goode EL, Goodman MT, Goodman G, Grankvist K, Greene MH, Gronberg H, Gronwald J, Guénel P, Håkansson N, Hall P, Hamann U, Hamdy FC, Hamilton RJ, Hampe J, Haugen A, Heitz F, Herrero R, Hillemanns P, Hoffmeister M, Høgdall E, Hong YC, Hopper JL, Houlston R, Hulick PJ, Hunter DJ, Huntsman DG, Idos G, Imyanitov EN, Ingles SA, Isaacs C, Jakubowska A, James P, Jenkins MA, Johansson M, Johansson M, John EM, Joshi AD, Kaneva R, Karlan BY, Kelemen LE, Kühl T, Khaw KT, Khusnutdinova E, Kibel AS, Kiemeney LA, Kim J, Kjaer SK, Knight JA, Kogevinas M, Kote-Jarai Z, Koutros S, Kristensen VN, Kupryjanczyk J, Lacko M, Lam S, Lambrechts D, Landi MT, Lazarus P, Le ND, Lee E, Lejbkowicz F, Lenz HJ, Leslie G, Lessel D, Lester J, Levine DA, Li L, Li CI, Lindblom A, Lindor NM, Liu G, Loupakis F, Lubinski J, Maehle L, Maier C, Mannermaa A, Marchand LL, Margolin S, May T, McGuffog L, Meindl A, Middha P, Miller A, Milne RL, MacInnis RJ, Modugno F, Montagna M, Moreno V, Moysich KB, Mucci L, Muir K, Mulligan AM, Nathanson KL, Neal DE, Ness AR, Neuhausen SL, Nevanlinna H, Newcomb PA, Newcomb LF, Nielsen FC, Nikitina-Zake L, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olama AAA, Olopade OI, Olshan AF, Olsson H, Osorio A, Pandha H, Park JY, Pashayan N, Parsons MT, Pejovic T, Penney KL, Peters WHM, Phelan CM, Phipps AI, Plaseska-Karanfilska D, Pring M, Prokofyeva D, Radice P, Stefansson K, Ramus SJ, Raskin L, Rennert G, Rennert HS, van Rensburg EJ, Riggan MJ, Risch HA, Risch A, Roobol MJ, Rosenstein BS, Rossing MA, De Ruyck K, Saloustros E, Sandler DP, Sawyer EJ, Schabath MB, Schleutker J, Schmidt MK, Setiawan VW, Shen H, Siegel EM, Sieh W, Singer CF, Slattery ML, Sorensen KD, Southey MC, Spurdle AB, Stanford JL, Stevens VL, Stintzing S, Stone J, Sundfeldt K, Sutphen R, Swerdlow AJ, Tajara EH, Tangen CM, Tardón A, Taylor JA, Teare MD, Teixeira MR, Terry MB, Terry KL, Thibodeau SN, Thomassen M, Bjørge L, Tischkowitz M, Toland AE, Torres D, Townsend PA, Travis RC, Tung N, Tworoger SS, Ulrich CM, Usmani N, Vachon CM, Van Nieuwenhuysen E, Vega A, Aguado-Barrera ME, Wang Q, Webb PM, Weinberg CR, Weinstein S, Weissler MC, Weitzel JN, West CML, White E, Whittemore AS, Wichmann HE, Wiklund F, Winqvist R, Wolk A, Woll P, Woods M, Wu AH, Wu X, Yannoukakos D, Zheng W, Zienolddiny S, Ziogas A, Zorn KK, Lane JM, Saxena R, Thomas D, Hung RJ, Diergaarde B, McKay J, Peters U, Hsu L, García-Closas M, Eeles RA, Chenevix-Trench G, Brennan PJ, Haiman CA, Simard J, Easton DF, Gruber SB, Pharoah PDP, Price AL, Pasaniuc B, Amos CI, Kraft P, Lindström S: Publisher Correction: Shared heritability and functional enrichment across six solid cancers. 2019
Dörr HG, Penger T, Marx M, Rauh M, Oppelt PG, Völkl TKM: Adrenarche and pubarche in girls with turner syndrome during growth-promoting therapy with human growth hormone. 2019
Ditsch N, Untch M, Thill M, Müller V, Janni W, Albert US, Bauerfeind I, Blohmer J, Budach W, Dall P, Diel I, Fasching PA, Fehm T, Friedrich M, Gerber B, Hanf V, Harbeck N, Huober J, Jackisch C, Kolberg-Liedtke C, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Möbus V, Müller-Schimpfle M, Mundhenke C, Nitz U, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Wenz F, Witzel I, Wöckel A: AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019. 2019
Kehl S, Weiss C, Dammer U, Berlit S, Große-Steffen T, Faschingbauer F, Sütterlin M, Beckmann MW, Schneider MO: Induction of Labour in Growth Restricted and Small for Gestational Age Foetuses - A Historical Cohort Study. 2019
Seelbach-Goebel B, Beckmann MW: Berlin, 05.04.2018. Statement of the German Society for Gynecology and Obstetrics (DGGG) on the Report Plan S17-02 Version 1.0 Screening of Streptococci of the serological Group B 26.02.2018 2019
Vachon CM, Scott CG, Tamimi RM, Thompson DJ, Fasching PA, Stone J, Southey MC, Winham S, Lindström S, Lilyquist J, Giles GG, Milne RL, MacInnis RJ, Baglietto L, Li J, Czene K, Bolla MK, Wang Q, Dennis J, Haeberle L, Eriksson M, Kraft P, Luben R, Wareham N, Olson JE, Norman A, Polley EC, Maskarinec G, Le Marchand L, Haiman CA, Hopper JL, Couch FJ, Easton DF, Hall P, Chatterjee N, Garcia-Closas M: Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. 2019
Mueller V, Huober J, Volz B, Overkamp F, Kolberg HC, Hadji P, Haeberle L, Ettl J, Hartkopf AD, Lux MP, Lueftner DI, Wallwiener M, Taran FA, Beckmann MW, Belleville E, Wimberger P, Hielscher C, Geberth M, Lermann J, Abenhardt A, Kurbacher C, Wuerstlein R, Thomssen C, Untch M, Janni W, Fehm TN, Brucker SY, Wallwiener D, Schneeweiss A, Fasching PA, Tesch H: PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/metastatic setting (NCT02338167) 2019
Fejzo MS, Fasching PA, Schneider MO, Schwitulla J, Beckmann MW, Schwenke E, MacGibbon KW, Mullin PM: Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality. 2019
Denkert C, Budczies J, Regan MM, Loibl S, Dell'Orto P, von Minckwitz G, Mastropasqua MG, Solbach C, Thürlimann B, Mehta K, Blohmer JU, Colleoni M, Müller V, Klauschen F, Ataseven B, Engels K, Kammler R, Pfitzner BM, Dietel M, Fasching PA, Viale G: Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial. 2019
Stonawski V, Frey S, Golub Y, Rohleder N, Kriebel J, Goecke TW, Fasching PA, Beckmann MW, Kornhuber J, Kratz O, Moll GH, Heinrich H, Eichler A: Associations of prenatal depressive symptoms with DNA methylation of HPA axis-related genes and diurnal cortisol profiles in primary school-aged children. 2019
Slamon DJ, Fasching PA, Patel R, Verma S, Hurvitz SA, Chia SKL, Crown J, Martin M, Barrios CH, Spera G, Lopez C, Hor I, Pelov D, Hughes G, Nawinne M, Hortobagyi GN: NATALEE: Phase III study of ribociclib (RIBO) plus endocrine therapy (ET) as adjuvant treatment in hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer (EBC). 2019
Janning M, Müller V, Vettorazzi E, Cubas-Cordova M, Gensch V, Ben-Batalla I, Zu Eulenburg C, Schem C, Fasching PA, Schnappauf B, Karn T, Fehm T, Just M, Kühn T, Holms F, Overkamp F, Krabisch P, Rack B, Denkert C, Untch M, Tesch H, Rezai M, Kittel K, Pantel K, Bokemeyer C, Loibl S, von Minckwitz G, Loges S: Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial. 2019
Koch MC, Lermann J, van de Roemer N, Renner SK, Burghaus S, Hackl J, Dittrich R, Kehl S, Oppelt PG, Hildebrandt T, Hack CC, Pöhls UG, Renner SP, Thiel FC: Clarifications concerning the commentary "Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed". 2019
Thill M, Jackisch C, Janni W, Müller V, Albert US, Bauerfeind I, Blohmer J, Budach W, Dall P, Diel I, Fasching PA, Fehm T, Friedrich M, Gerber B, Hanf V, Harbeck N, Huober J, Kolberg-Liedtke C, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Möbus V, Müller-Schimpfle M, Mundhenke C, Nitz U, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Wenz F, Witzel I, Wöckel A, Ditsch N: AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019. 2019
Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fiessler C, Hein A, Häberle L, Jud SM, Lux MP, Janni W, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kümmel S, Martin B, Thomssen C, Graf H, Wolf C, Bayer CM, Hack CC, Almstedt K, Gass P, Heindl F, Brodkorb TF, Nabieva N, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Wallwiener D, Rack B, Fehm T, Rody A, Maass N, Beckmann MW, Fasching PA, Rauh C: Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. 2019
Reimann H, Nguyen A, Huebner H, Erber R, Bausenwein J, Van der Meijden ED, Lux MP, Jud S, Griffioen M, Rauh C, Sanborn JZ, Benz SC, Rabizadeh S, Beckmann MW, Mackensen A, Ruebner M, Fasching P, Kremer AN: Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+breast cancer 2019
Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M: Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia. 2019
Scharl AJ, Beckmann MW: Berlin, 24.01.2019. 271 Statement of the German Society for Gynecology and Obstetrics (DGGG) on the Health Information Draft from the IQWiG on "Ovarian Cysts" 2019
Fasching PA, Schneeweiss A, Kolberg HC, Ettl J, Fehm TN, Overkamp F, Lüftner D: Translational highlights in breast cancer research and treatment: recent developments with clinical impact. 2019
Reimann H, Nguyen A, Huebner H, Erber R, Bausenwein J, Van der Meijden ED, Lux MP, Jud S, Griffioen M, Rauh C, Sanborn JZ, Benz SC, Rabizadeh S, Beckmann MW, Mackensen A, Ruebner M, Fasching PA, Kremer AN: Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+breast cancer 2019
Trapp E, Janni W, Schindlbeck C, Jückstock J, Andergassen U, de Gregorio A, Alunni-Fabbroni M, Tzschaschel M, Polasik A, Koch JG, Friedl TWP, Fasching PA, Haeberle L, Fehm T, Schneeweiss A, Beckmann MW, Pantel K, Mueller V, Rack B, Scholz C, SUCCESS Study Group: Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis. 2019
Furlanetto J, Nekljudova V, Schneeweiss A, Thode C, Denkert C, Untch M, Bassy M, Karn T, Fasching PA, Stickeler E, Schem C, Marme F, Grischke EM, van Mackelenbergh M, Strik D, Schmatloch S, Mueller V, Loibl S: Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC) 2019
Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, Butzow R, Campbell IG, Chang-Claude J, Chen K, Cook LS, Cramer DW, deFazio A, Dennis J, Doherty JA, Dörk T, Eccles DM, Edwards DV, Fasching PA, Fortner RT, Gayther SA, Giles GG, Glasspool RM, Goode EL, Goodman MT, Gronwald J, Harris HR, Heitz F, Hildebrandt MA, Høgdall E, Høgdall CK, Huntsman DG, Kar SP, Karlan BY, Kelemen LE, Kiemeney LA, Kjaer SK, Koushik A, Lambrechts D, Le ND, Levine DA, Massuger LF, Matsuo K, May T, McNeish IA, Menon U, Modugno F, Monteiro AN, Moorman PG, Moysich KB, Ness RB, Nevanlinna H, Olsson H, Onland-Moret NC, Park SK, Paul J, Pearce CL, Pejovic T, Phelan CM, Pike MC, Ramus SJ, Riboli E, Rodriguez-Antona C, Romieu I, Sandler DP, Schildkraut JM, Setiawan VW, Shan K, Siddiqui N, Sieh W, Stampfer MJ, Sutphen R, Swerdlow AJ, Szafron LM, Teo SH, Tworoger SS, Tyrer JP, Webb PM, Wentzensen N, White E, Willett WC, Wolk A, Woo YL, Wu AH, Yan L, Yannoukakos D, Chenevix-Trench G, Sellers TA, Pharoah PDP, Zheng W, Long J: Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. 2019
Woeckel A, Decker T, Fasching PA, Jackisch C, Lüftner D, Marme F, Reimer T, Roos C: Real-world effectiveness of ribociclib plus aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Baseline data from the RIBANNA study. 2019
Witzel I, Loibl S, Wirtz R, Fasching PA, Denkert C, Weber K, Lück HJ, Huober J, Karn T, Mackelenbergh MV, Marmé F, Schem C, Stickeler E, Untch M, Müller V: Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial. 2019
Stelzl P, Kehl S, Rath W: Maintenance tocolysis: a reappraisal of clinical evidence. 2019
Wallwiener M, Nabieva N, Feisst M, Fehm T, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Popovic M, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesselt T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauss T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Schmidt K, Belleville E, Brucker SY, Hadji P, Beckmann MW, Wallwiener D, Kümmel S, Hartkopf A, Fasching PA: Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study. 2019
Mamounas EP, Geyer CE, Huang CS, Mano MS, Loibl S, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wuelfing P, Shao ZM, Caremoli ER, Wu HY, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, von Minckwitz G: KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer 2019
Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M: Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up. 2019
Scharl AJ, Beckmann MW: Berlin, 12.03.2019 275th Statement of the Working Group on Gynecological Oncology (AGO) of the German Society for Gynecology and Obstetrics (DGGG) about the IQWiG Health Information "Therapy-related Hair Loss" 2019
Matthies LM, Taran FA, Keilmann L, Schneeweiss A, Simoes E, Hartkopf AD, Sokolov AN, Walter CB, Sickenberger N, Wallwiener S, Feisst M, Gass P, Lux MP, Schuetz F, Fasching PA, Sohn C, Brucker SY, Graf J, Wallwiener M: An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study. 2019
Schneeweiss A, Lux MP, Hartkopf AD, Volz B, Kolberg HC, Hadji P, Tesch H, Haeberle L, Ettl J, Lueftner DI, Wallwiener M, Mueller V, Beckmann MW, Belleville E, Wimberger P, Hielscher C, Geberth M, Lermann J, Abenhardt W, Kurbacher C, Wuerstlein R, Thomssen C, Untch M, Overkamp F, Huober J, Taran FA, Janni W, Wallwiener D, Brucker SY, Fasching PA, Fehm TN: Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167) 2019
Nabieva N, Häberle L, Brucker SY, Janni W, Volz B, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kuemmel S, Martin B, Thomssen C, Graf H, Wolf C, Lux MP, Bayer CM, Rauh C, Hack CC, Almstedt K, Gass P, Heindl F, Brodkorb T, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Rack B, Beckmann MW, Fehm T, Rody A, Maass N, Hein A, Fasching PA: Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients. 2019
Eckstein M, Hartmann A, Strissel P, Strick R, Wach S, Taubert H, Wullich B, Geppert C, Weyerer V, Stoehr R, Rubner M, Fasching PA, Rabizadeh S, Benz S, Haller F, Moskalev E, Toegel L: Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC) 2019
Turner NC, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, Mina LA, Balmana J, Fasching PA, Hurvitz SA, Wardley AM, Chappey C, Hannah AL, Robson ME: A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). 2019
Beckmann MW: Dear Readers 2019
Sinn BV, Weber KE, Schmitt WD, Fasching PA, Symmans WF, Blohmer JU, Karn T, Taube ET, Klauschen F, Marmé F, Schem C, Stickeler E, Ataseven B, Huober J, von Minckwitz G, Seliger B, Denkert C, Loibl S: Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy. 2019
Lux MP, Nabieva N, Hartkopf AD, Huober J, Volz B, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Häberle L, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wimberger P, Hielscher C, Geberth M, Abenhardt W, Kurbacher C, Wuerstlein R, Thomssen C, Untch M, Fasching PA, Janni W, Fehm TN, Wallwiener D, Schneeweiss A, Brucker SY: Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry. 2019
Regensburger AP, Konrad V, Trollmann R, Eyüpoglu IY, Huebner H, Zierk J, Völkl TMK, Fahlbusch FB: Treatment of severe traumatic brain injury in German pediatric intensive care units-a survey of current practice. 2019
Kehl S, Weiss C, Dammer U, Berlit S, Große-Steffen T, Faschingbauer F, Sütterlin M, Beckmann MW, Schneider MO: [Induction of Labour In Growth Restricted and Small for Gestational Age Fetuses - A Historical Cohort Study]. 2019
Scharl AJ, Beckmann MW: Berlin, 25.04.2019 277th Statement of the Commission Mamma of the Working Group on Gynecological Oncology (AGO) e. V. in the German Society of Gynecology and Obstetrics e. V. about Palbociclib (Breast Cancer) - Benefit Assessment according to 35a SGB V 2019
Mayer IA, Prat A, Egle D, Blau S, Fidalgo JAP, Gnant M, Fasching PA, Colleoni M, Wolff AC, Winer EP, Singer CF, Hurvitz S, Estévez LG, van Dam PA, Kümmel S, Mundhenke C, Holmes F, Babbar N, Charbonnier L, Diaz-Padilla I, Vogl FD, Sellami D, Arteaga CL: A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB). 2019
Sinn BV, Loibl S, Karn T, Untch M, Kunze CA, Weber KE, Treue D, Wagner K, Hanusch CA, Klauschen F, Fasching PA, Huober J, Zahm DM, Jackisch C, Thomalla J, Blohmer JU, van Mackelenbergh M, Rhiem K, Felder B, von Minckwitz G, Burchardi N, Schneeweiss A, Denkert C: Pre-therapeutic PD-L1 expression and dynamics of Ki-67 and gene expression during neoadjuvant immunecheckpoint blockade and chemotherapy to predict response within the GeparNuevo trial 2019
Kehl S, Born T, Weiss C, Faschingbauer F, Pretscher J, Beckmann MW, Sütterlin M, Dammer U: Induction of labour with sequential double-balloon catheter and oral misoprostol versus oral misoprostol alone in obese women. 2019
Furlanetto J, von Minckwitz G, Lederer B, Möbus V, Schneeweiss A, Huober J, Fasching PA, Gerber B, Bauerfeind I, Nitz U, Lück HJ, Hanusch C, Thomssen C, Untch M, Nekljudova V, Mehta K, Loibl S: Fatal events during clinical trials: an evaluation of deaths during breast cancer studies. 2019
Hadji P, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, Distelrath A, Fasching PA, Lux MP, Lüftner D, Janni W, Muth M, Kreuzeder J, Quiering C, Grischke EM, Tesch H: The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial. 2019
Beckmann MW: Dear Readers 2019
Welslau M, Hartkopf AD, Müller V, Wöckel A, Lux MP, Janni W, Ettl J, Lüftner D, Belleville E, Schütz F, Fasching PA, Kolberg HC, Nabieva N, Overkamp F, Taran FA, Brucker SY, Wallwiener M, Tesch H, Schneeweiss A, Fehm TN: Update Breast Cancer 2019 Part 5 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer. 2019
Hartkopf AD, Müller V, Wöckel A, Lux MP, Janni W, Ettl J, Belleville E, Schütz F, Fasching PA, Kolberg HC, Welslau M, Overkamp F, Taran FA, Brucker SY, Wallwiener M, Tesch H, Fehm TN, Schneeweiss A, Lüftner D: Translational Highlights in Breast and Ovarian Cancer 2019 - Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy. 2019
Schneeweiss A, Möbus V, Tesch H, Hanusch C, Denkert C, Lübbe K, Huober J, Klare P, Kümmel S, Untch M, Kast K, Jackisch C, Thomalla J, Ingold-Heppner B, Blohmer JU, Rezai M, Frank M, Engels K, Rhiem K, Fasching PA, Nekljudova V, von Minckwitz G, Loibl S: Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial. 2019
Kuehn C, Tauchi M, Furtmair R, Urschel K, Raaz-Schrauder D, Neumann AL, Frohberger SJ, Hoerauf A, Regus S, Lang W, Sagban TA, Stumpfe FM, Achenbach S, Hübner MP, Dietel B: Filarial extract of Litomosoides sigmodontis induces a type 2 immune response and attenuates plaque development in hyperlipidemic ApoE-knockout mice. 2019
Schnürch HG, Ackermann S, Alt-Radtke CD, Angleitner L, Barinoff J, Beckmann MW, Böing C, Dannecker C, Fehm T, Gaase R, Gass P, Gebhardt M, Gieseking F, Günthert A, Hack CC, Hantschmann P, Horn LC, Koch MC, Letsch A, Mallmann P, Mangold B, Marnitz S, Mehlhorn G, Paradies K, Reinhardt MJ, Tholen R, Torsten U, Weikel W, Wölber L, Hampl M: Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018). 2019
Seelbach-Goebel B, Beckmann MW: Berlin, 24.08.2018 Statement of the German Society for Gynecology and Obstetrics (DGGG) and the German Society for Perinatal Medicine (DGPM) on the IQWIG Preliminary Report S17/02-Screening of Streptococci of serological Group B as a Part of Preventive Examinations according to Maternity Guidelines 2019
Laakmann E, Witzel I, Fasching PA, Rezai M, Schem C, Solbach C, Tesch H, Klare P, Schneeweiss A, Salat C, Zahm DM, Blohmer JU, Ingold-Heppner B, Huober J, Hanusch C, Jackisch C, Reinisch M, Untch M, von Minckwitz G, Nekljudova V, Müller V, Loibl S: Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto. 2019
Villegas SL, Lederer B, Untch M, Holms F, Ulmer HU, Diebold K, Fasching PA, Weber K, Schmitt WD, Tesch H, Rezai M, Marme F, Sinn B, Hackmann J, Schneeweiss A, Tannapfel A, Nekljudova V, Denkert C, Loibl S: Similarities between low hormone receptor positive and hormone receptor negative breast cancer: An analysis of 4366 patients from multicenter clinical trials 2019
Lermann J, Topal N, Renner SP, Beckmann MW, Burghaus S, Adler W, Heindl F: Comparison of preoperative and postoperative sexual function in patients with deeply infiltrating endometriosis with and without bowel resection. 2019
Untch M, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Schem C, Wiebringhaus H, Kümmel S, Warm M, Fasching PA, Just M, Hanusch C, Hackmann J, Blohmer JU, Rhiem K, Schmitt WD, Furlanetto J, Gerber B, Huober J, Nekljudova V, von Minckwitz G, Loibl S: NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto. 2019
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE, KATHERINE Investigators , Fein L, Kaen L, Lerzo G, Egle D, Greil R, Hubalek M, Singer C, Steger G, Dirix L, Duhoux F, Jerusalem G, Renard V, Araujo R, Boukai A, Hegg R, Lima JP, Mano M, Morelle A, Muller AP, Paiva CE, Pedrini JL, Pinczowski H, Santos L, Teich NL, Testa L, Wiermann E, Basik M, Davidson JA, Goel R, Logan D, Lohrisch C, Mackey J, Martin LA, Paterson A, Prady C, Provencher L, Robidoux A, Sridhar S, Thirlwell M, Tonkin K, Warr D, Li W, Liao N, Pang D, Shao Z, Shen K, Wang S, Wang Y, Franco S, Gonzalez M, Quiroga Echeverri A, Yepes A, Kubala E, Melichar B, Paulik A, Zimovjanova M, Bonnefoi H, Bourgeois H, Brain E, Curtit E, D'Hondt V, Dieras V, Espie M, Extra JM, Gligorov J, Grenier J, Levy C, Mouret-Reynier MA, Nabholtz JM, Orfeuvre H, Petit T, Pierga JY, Pivot X, Romieu G, Saghatchian-D'Assignies M, Teixeira L, Thery JC, Veyret C, Aktas B, Bauer S, Belau A, Blohmer JU, Eidtmann H, Fasching P, Fehm T, Feisel-Schwickardi G, Fischer HH, Gerteis A, Grafe A, Graffunder G, Grischke EM, Hackmann J, Harbeck N, Heinrich B, Hielscher C, Hoffmann O, Jackisch C, Janni W, Just M, Klare P, Kronawitter U, Kühn T, Kümmel S, Kunz G, Lantzsch T, Lübbe K, Meinerz W, Mundhenke C, Negwer M, Neunhöffer T, Overkamp F, Park-Simon TW, Rack B, Rautenberg B, Reimer T, Rezai M, Salat C, Schem C, Schlag R, Schmatloch S, Schnappauf B, Schneeweiss A, Schrauder M, Schumacher C, Schwaner I, Solbach C, Stickeler E, Tesch H, Thalmann I, Thomssen C, Untch M, Wachsmann GT, Warm M, Wiebringhaus H, Wulfing P, Mavroudis D, Papazisis K, Castro-Salguero H, Hernandez-Monroy CE, Cheung FY, Kwong A, Ng TY, Soong SI, Coate L, Crown J, Hennessy B, Higgins M, Keane M, Kelly C, Moylan E, Nasim S, O'Reilly S, Ben Baruch N, Geffen D, Kaufman B, Rosengarten O, Uziely B, Yerushalmi R, Allegrini G, Bianchi G, Brandes A, Cazzaniga M, Cinieri S, Colleoni MA, Conte PF, De Laurentiis M, De Placido S, Del Mastro L, Fiorio E, Fontana A, Generali D, Gianni L, Marchetti P, Molino AM, Montemurro F, Rota Caremoli E, Tonini G, Zamagni C, Arce Salinas C, Chavarri Guerra Y, Hernandez CA, Lopez-Lopez F, Martinez G, Villarreal Garza CM, Alcedo JC, Lopez RI, Aleman D, Becerra J, Desposorio C, Kobashigawa A, Pimentel P, Pesic J, Stamatovic L, Coccia-Portugal M, Cullis SM, Maart K, Moodley SD, Pienaar F, Rapoport B, Alvarez Lopez I, Carabantes F, Echarri Gonzalez MJ, Fernandez Perez I, Garcia Estevez L, Illarramendi Mañas JJ, Llorente Domenech RM, Mele Olive M, Muñoz Mateu M, Redondo Sanchez A, Rodriguez Sanchez C, Ruiz Borrego M, Ruiz Simo A, Bjöhle J, Del Val Munoz O, Hatschek T, Loman N, Schreiber A, Tausch C, Chen SC, Huang CS, Liu MC, Tseng LM, Yang Y, Yeh DC, Aliustaoglu M, Cicin I, Elkiran ET, Evrensel T, Gumus M, Karabulut B, Uslu R, Yildirim ME, Adamson D, Bradley C, Braybrooke J, Chan S, Dhadda A, Joffe J, Lowdell C, Mansi J, Michie C, Mohanamurali J, Perren T, Rea D, Scatchard K, Stebbing J, Wardley A, Wheatley D, Winter M, Abraham J, Avery T, Bear HD, Boyle LE, Brufsky A, Chambers M, Chang J, Charles A, Chaudhry M, Cobleigh M, Conlin A, Constantino S, DeFusco P, DiGiovanna M, Doyle T, Farrar W, Fehrenbacher L, Flaherty L, Flynn PJ, Gayle A, Giordano S, Han H, Hantel A, Hargis J, Hershman D, Ibach D, Jaslow R, Julian T, Karwal M, Kramer R, Krie A, Krill-Jackson E, Limentani S, Link J, Mamounas E, Mäurer M, McCarron E, Mehta R, Menter A, Murali S, Nguyen B, Oldham D, Padula G, Pajon E, Patel K, Paterson A, Phelan J, Polikoff J, Resta R, Rimawi M, Riseberg D, Robertson J, Romond E, Seaward S, Seeger J, Shah N, Shalaby I, Sinclair S, Steen P, Sturtz K, Tamkus D, Tan AR, Thomas A, Tolentino A, Toppmeyer D, Trehan S, Valero V, Vaughn C, Wahl T, Waisman J, Wapnir I, Weisberg TF, Wickerham DL, Yost K, Zakalik D, Zapas J, Zera R, Zhang W: Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. 2019
Fasching PA, Eggemann H, Krocker J, Haeberle L, Volz B, Kleine-Tebbe A, Blohmer JU, Kittel K, Hufnagel M, Janni W, Emons G, Simon E, Koehler U, Thomssen C, Kohls A, Beckmann MW, Hielscher C, Krabisch P, Zeiser T, Brodkorb T, Baier F, Nabieva N, Kellner S, Untch M, Stadie S, Budner M, Breitbach GP, Keller M, Stickeler E, Kuehn T, Tolkmitt M, Belau AK, Schmidt M, Ulm K, Kuemmel S: Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dose dense regimen with epirubicin and paclitaxel 2019
Schütz F, Fasching PA, Welslau M, Hartkopf AD, Wöckel A, Lux MP, Janni W, Ettl J, Lüftner D, Belleville E, Kolberg HC, Overkamp F, Taran FA, Brucker SY, Wallwiener M, Tesch H, Fehm TN, Schneeweiss A, Müller V: Update Breast Cancer 2019 Part 4 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer. 2019
Fasching PA, Hartkopf AD, Gass P, Häberle L, Akpolat-Basci L, Hein A, Volz B, Taran FA, Nabieva N, Pott B, Overkamp F, Einarson H, Hadji P, Tesch H, Ettl J, Lüftner D, Wallwiener M, Müller V, Janni W, Fehm TN, Schneeweiss A, Untch M, Pott D, Lux MP, Geyer T, Liedtke C, Seeger H, Wetzig S, Hartmann A, Schulz-Wendtland R, Belleville E, Wallwiener D, Beckmann MW, Brucker SY, Kolberg HC: Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis. 2019
Jank P, Loibl S, Fasching PA, Karn T, Marme F, Mueller V, Schem C, Stickeler E, Lederer B, Denkert C: Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials 2019
Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW: Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). 2019
Scharl AJ, Beckmann MW: Berlin, 22.10.2018. 270th Statement of the Working Group of Gynecological Oncology (AGO) e. V. in the German Society for Gynecology and Obstetrics (DGGG) e. V. on the Subject of Pertuzumab (Breast Cancer) - Benefit Assessment according to 35a SGB V 2019
Banys-Paluchowski M, Witzel I, Aktas B, Fasching PA, Hartkopf A, Janni W, Kasimir-Bauer S, Pantel K, Schön G, Rack B, Riethdorf S, Solomayer EF, Fehm T, Müller V: The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer. 2019
Witzel ID, Riecke K, Laakmann E, Weide R, Neunhoeffer T, Park-Simon TW, Schmidt M, Fasching PA, Hesse T, Polasik A, Mohrmann S, Wuerschmidt F, Schem C, Bechtner C, Wuerstlein R, Fehm T, Moebus V, Burchardi N, Loibl S, Mueller V: Validation of different prognostic scores in breast cancer patients with brain metastases of the BMBC registry (GBG-79) 2019
Raffel N, Dittrich R, Bäuerle T, Seyler L, Fattahi A, Hoffmann I, Leal-Egaña A, Beckmann MW, Boccaccini AR, Liverani L: Novel approach for the assessment of ovarian follicles infiltration in polymeric electrospun patterned scaffolds. 2019
Loibl S, Treue D, Budczies J, Weber K, Stenzinger A, Schmitt WD, Weichert W, Jank P, Furlanetto J, Klauschen F, Karn T, Pfarr N, von Minckwitz G, Möbs M, Jackisch C, Sers C, Schneeweiss A, Fasching PA, Schem C, Hummel M, van Mackelenbergh M, Nekljudova V, Untch M, Denkert C: Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial. 2019
Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, Distelrath A, Fasching PA, Lux MP, Lüftner D, Hadji P, Janni W, Muth M, Kreuzeder J, Quiering C, Taran FA: Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial. 2019
Koch MC, Lermann J, van de Roemer N, Renner SK, Burghaus S, Hackl J, Dittrich R, Kehl S, Oppelt PG, Hildebrandt T, Hack CC, Pöhls UG, Renner SP, Thiel FC: Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app. 2019
Schmidt M, Rauh M, Schmid MC, Huebner H, Ruebner M, Wachtveitl R, Cordasic N, Rascher W, Menendez-Castro C, Hartner A, Fahlbusch FB: Influence of Low Protein Diet-Induced Fetal Growth Restriction on the Neuroplacental Corticosterone Axis in the Rat. 2019
Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J: Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman. 2019
Deniz M, DeGregorio A, DeGregorio N, Bekes I, Widschwendter P, Schochter F, Ernst K, Scholz C, Bauer EC, Aivazova-Fuchs V, Weissenbacher T, Kost B, Jueckstock J, Andergassen U, Steidl J, Trapp E, Fasching PA, Häberle L, Beckmann MW, Schneeweiss A, Schrader I, Janni W, Rack B, Friedl TW: Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study. 2019
Huang M, Qi CZ, Ramsey S, Briggs A, Zhao J, Haiderali A, Karantza V, Xie J, Gu C, Fasching PA: Evaluation of pathological complete response as a trial-level surrogate for long-term survival outcomes among triple-negative breast cancer patients receiving neoadjuvant therapy 2019
Burghaus S, Hildebrandt T, Fahlbusch C, Heusinger K, Antoniadis S, Lermann J, Hackl J, Häberle L, Renner SP, Fasching PA, Beckmann MW, Blum S: Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis. 2019
Seelbach-Goebel B, Beckmann MW: Berlin, 14.03.2017 Statement of the German Society for Gynecology and Obstetrics (DGGG) on "P15-02 Invitation Letters and Decision Aid for Cervical Cancer Screening" 2019
Ooi BNS, Loh H, Ho PJ, Milne RL, Giles G, Gao C, Kraft P, John EM, Swerdlow A, Brenner H, Wu AH, Haiman C, Evans DG, Zheng W, Fasching PA, Castelao JE, Kwong A, Shen X, Czene K, Hall P, Dunning A, Easton D, Hartman M, Li J: The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis. 2019
Woeckel A, Fasching PA, Guderian G, Heim J, Jackisch C, Lück HJ, Lueftner D, Marme F, Reimer T, Decker T: RIBANNA Real-world evidence of ribociclib plus aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line therapy for postmenopausal women with HR+, HER2 advanced breast cancer (aBC) 2019
Raffel N, Klemm K, Dittrich R, Hoffmann I, Söder S, Beckmann MW, Lotz L: The effect of bpV(HOpic) on in vitro activation of primordial follicles in cultured swine ovarian cortical strips. 2019
Hurvitz SA, Martin M, Jung KH, Huang CS, Harbeck N, Valero V, Stroyakovskiy D, Wildiers H, Campone M, Boileau JF, Fasching PA, Afenjar K, Spera G, Lopez-Valverde V, Song C, Trask P, Boulet T, Sparano JA, Symmans WF, Thompson AM, Slamon D: Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study. 2019
Krugmann J, Schwarz CL, Melcher B, Sterlacci W, Ozalinskaite A, Lermann J, Agaimy A, Vieth M: Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015. 2019
Sommer M, Kirchner M, Gulden C, Egloffstein S, Lux MP, Beckmann MW, Mackensen A, Prokosch HU: Design and Implementation of a Single Source Multipurpose Hospital-Wide Clinical Trial Registry. 2019
Hug K, Tauchi M, Raaz-Schrauder D, Stumpfe F, Achenbach S, Dietel-Schor B, Urschel K: SHEAR STRESS-DEPENDENT EXPRESSION OF GLYPICAN-4 AND HEPARAN SULFATE IN DIFFERENT PRIMARY HUMAN ENDOTHELIAL CELLS 2019
Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J: Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease. 2019
Stuebs FA, Schulmeyer CE, Mehlhorn G, Gass P, Kehl S, Renner SK, Renner SP, Geppert C, Adler W, Hartmann A, Beckmann MW, Koch MC: Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study. 2019
Fasching PA, Quek RGW, Bhattacharyya H, Hurvitz SA, Rugo HS, Ettl J: Impact of objective response (OR) on patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA) mutation in the phase III EMBRACA trial 2019
Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, Behrens S, Bermisheva M, Blomqvist C, Bogdanova N, Bojesen SE, Brauch H, Brenner H, Burwinkel B, Canzian F, Chan TL, Chang-Claude J, Chanock SJ, Choi JY, Christiansen H, Clarke CL, Couch FJ, Czene K, Daly MB, dos-Santos-Silva I, Dwek M, Eccles DM, Ekici AB, Eriksson M, Evans DG, Fasching PA, Figueroa J, Flyger H, Fritschisl L, Gabrielson M, Gago-Dominguez M, Gao C, Gapstur SM, García-Closas M, Garcia-Saenz JA, Gaudet MM, Giles GG, Goldberg MS, Goldgar DE, Guénel P, Haeberle L, Haiman CA, Håkansson N, Hall P, Hamann U, Hartman M, Hauke J, Hein A, Hillemanns P, Hogervorst FBL, Hooning MJ, Hopper JL, Howell T, Huo DZ, Ito H, Iwasaki M, Jakubowska A, Janni W, John EM, Jung A, Kaaks R, Kang D, Kapoor PM, Khusnutdinova E, Kim SW, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kwon A, Lambrechts D, Le Marchand L, Li JM, Lindström S, Linet M, Lo WY, Long JR, Lophatananon A, Lubinski J, Manoochehri M, Manoukian S, Margolin S, Martinez E, Matsuo K, Mavroudis D, Meindl A, Menon U, Milne RL, Taib NAM, Muir K, Mulligan AM, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Offit K, Olopade OI, Olshan AF, Olson JE, Olsson H, Park SK, Park-Simon TW, Peto J, Plaseska-Karanfilska D, Pohl-Rescigno E, Presneau N, Rack B, Radice P, Rashid MU, Rennert G, Rennert HS, Romero A, Ruebner M, Saloustros E, Schmidt MK, Schmutzler RK, Schneider MO, Schoemaker MJ, Scott C, Shen CY, Shu XO, Simard J, Slager S, Smichkoska S, Southey MC, Spinelli JJ, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper WJ, Teo SH, Terry MB, Toland AE, Tollenaar RAEM, Torres D, Torres-Mejia G, Troester MA, Truong T, Tsugane S, Untch M, Vachon CM, van den Ouweland AMW, van Veen EM, Vijai J, Wendt C, Wolk A, Yu JC, Zheng W, Ziogas A, Ziv E, Dunning AM, Pharoah PDP, Schindler D, Devilee P, Easton DF, Balleine R, Baxter R, Braye S, Carpenter J, Dahlstrom J, Forbes J, Lee CS, Marsh D, Morey A, Pathmanathan N, Scott R, Simpson P, Spigelman A, Wilcken N, Yip D, Zeps N, Borresen-Dale AL, Alnaes GIG, Sahlberg KK, Ottestad L, Kåresen R, Schlichting E, Holmen MM, Sauer T, Haakensen V, Engebråten O, Naume B, Fossa A, Kiserud CE, Reinertsen KV, Helland Å, Riis M, Geisler J, ABCTB Investigators NBCS Collaborators: Two truncating variants in FANCC and breast cancer risk 2019
Scharl AJ, Beckmann MW: 257a Statement by the German Society for Gynaecology and Obstetrics e. V. (DGGG) on biomarker-based Tests to decide whether or not to use adjuvant systemic Chemotherapy for primary Breast Cancer 2019
Schink M, Konturek PC, Herbert SL, Renner SP, Burghaus S, Blum S, Fasching PA, Neurath MF, Zopf Y: Different nutrient intake and prevalence of gastrointestinal comorbidities in women with endometriosis. 2019
Zack F, Zinka B, Beckmann MW, Banaschak S, Fischer H, Gabriel P, Gerber B, Costa SD, Ledwon P, Schwenzer T, Buttner A: Venous air embolism due to vaginal injuries through sexual intercourse. Critical analysis and review of the literature on frequency and diagnostics 2019
Liverani L, Raffel N, Fattahi A, Preis A, Hoffmann I, Boccaccini AR, Beckmann MW, Dittrich R: Electrospun patterned porous scaffolds for the support of ovarian follicles growth: a feasibility study. 2019
Banys-Paluchowski M, Wunderle M, Fehm TN, Arnold N, Fasching PA: Event Report 11th Scientific Symposium of the AGO TraFo 2019
Ferreira MA, Gamazon ER, Al-Ejeh F, Aittomäki K, Andrulis IL, Anton-Culver H, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, Azzollini J, Balmana J, Barnes DR, Barrowdale D, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bia?kowska K, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, Borg A, Brauch H, Brenner H, Broeks A, Burwinkel B, Caldes T, Caligo MA, Campa D, Campbell I, Canzian F, Carter J, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Christiansen H, Chung WK, Claes KBM, Clarke CL, EMBRACE Collaborators , GC-HBOC Study Collaborators , GEMO Study Collaborators , Couch FJ, Cox A, Cross SS, Czene K, Daly MB, de la Hoya M, Dennis J, Devilee P, Diez O, Dörk T, Dunning AM, Dwek M, Eccles DM, Ejlertsen B, Ellberg C, Engel C, Eriksson M, Fasching PA, Fletcher O, Flyger H, Friedman E, Frost D, Gabrielson M, Gago-Dominguez M, Ganz PA, Gapstur SM, Garber J, García-Closas M, García-Sáenz JA, Gaudet MM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Haiman CA, Hall P, Hamann U, He W, Heyworth J, Hogervorst FBL, Hollestelle A, Hoover RN, Hopper JL, Hulick PJ, Humphreys K, Imyanitov EN, ABCTB Investigators , HEBON Investigators , BCFR Investigators , Isaacs C, Jakimovska M, Jakubowska A, James PA, Janavicius R, Jankowitz RC, John EM, Johnson N, Joseph V, Karlan BY, Khusnutdinova E, Kiiski JI, Ko YD, Jones ME, Konstantopoulou I, Kristensen VN, Laitman Y, Lambrechts D, Lazaro C, Leslie G, Lester J, Lesueur F, Lindström S, Long J, Loud JT, Lubi?ski J, Makalic E, Mannermaa A, Manoochehri M, Margolin S, Maurer T, Mavroudis D, McGuffog L, Meindl A, Menon U, Michailidou K, Miller A, Montagna M, Moreno F, Moserle L, Mulligan AM, Nathanson KL, Neuhausen SL, Nevanlinna H, Nevelsteen I, Nielsen FC, Nikitina-Zake L, Nussbaum RL, Offit K, Olah E, Olopade OI, Olsson H, Osorio A, Papp J, Park-Simon TW, Parsons MT, Pedersen IS, Peixoto A, Peterlongo P, Pharoah PDP, Plaseska-Karanfilska D, Poppe B, Presneau N, Radice P, Rantala J, Rennert G, Risch HA, Saloustros E, Sanden K, Sawyer EJ, Schmidt MK, Schmutzler RK, Sharma P, Shu XO, Simard J, Singer CF, Soucy P, Southey MC, Spinelli JJ, Spurdle AB, Stone J, Swerdlow AJ, Tapper WJ, Taylor JA, Teixeira MR, Terry MB, Teule A, Thomassen M, Thöne K, Thull DL, Tischkowitz M, Toland AE, Torres D, Truong T, Tung N, Vachon CM, van Asperen CJ, van den Ouweland AMW, van Rensburg EJ, Vega A, Viel A, Wang Q, Wappenschmidt B, Weitzel JN, Wendt C, Winqvist R, Yang XR, Yannoukakos D, Ziogas A, Kraft P, Antoniou AC, Zheng W, Easton DF, Milne RL, Beesley J, Chenevix-Trench G, Adlard J, Ahmed M, Barwell J, Brady A, Brewer C, Cook J, Davidson R, Donaldson A, Eason J, Eeles R, Evans DG, Gregory H, Hanson H, Henderson A, Hodgson S, Izatt L, Kennedy MJ, Lalloo F, Miller C, Morrison PJ, Ong KR, Perkins J, Porteous ME, Rogers MT, Side LE, Snape K, Walker L, Harrington PA, Arnold N, Auber B, Bogdanova-Markov N, Borde J, Caliebe A, Ditsch N, Dworniczak B, Engert S, Faust U, Gehrig A, Hahnen E, Hauke J, Hentschel J, Herold N, Honisch E, Just W, Kast K, Larsen M, Lemke J, Nguyen HP, Niederacher D, Ott CE, Platzer K, Pohl-Rescigno E, Ramser J, Rhiem K, Steinemann D, Sutter C, Varon-Mateeva R, Wang-Gohrke S, Weber BHF, Prieur F, Pujol P, Sagne C, Sevenet N, Sobol H, Sokolowska J, Stoppa-Lyonnet D, Vénat-Bouvet L, Balleine R, Baxter R, Braye S, Carpenter J, Dahlstrom J, Forbes J, Lee SC, Marsh D, Morey A, Pathmanathan N, Simpson P, Spigelman A, Wilcken N, Yip D, Heemskerk-Gerritsen BAM, Rookus MA, Seynaeve CM, van der Baan FH, van der Hout AH, van der Kolk LE, van der Luijt RB, van Deurzen CHM, van Doorn HC, van Engelen K, van Hest L, van Os TAM, Verhoef S, Vogel MJ, Wijnen JT, Miron A, Kapuscinski M, Bane A, Ross E, Buys SS, Conner TA: Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. 2019
Pfannstiel C, Strissel PL, Chiappinelli KB, Sikic D, Wach S, Wirtz R, Wullweber A, Taubert H, Breyer J, Otto W, Worst T, Burger M, Wullich B, Bolenz C, Fuhrich N, Geppert CI, Weyerer V, Stöhr R, Bertz S, Keck B, Erlmeier F, Erben P, Hartmann A, Strick R, Eckstein M: The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes. 2019
Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, Mina LA, Balmana J, Fasching PA, Hurvitz SA, Albacker LA, Frampton GM, Chelliserry J, Bycott P, Conte U, Wardley AM, Robson ME: Next-generation DNA sequencing (NGS) results for tumours from phase II ABRAZO study of talazoparib after platinum or cytotoxic non-platinum regimens in patients (pts) with advanced breast cancer (ABC) and germline BRCA1/2 (gBRCA) mutations 2019
Stumpfe FM, Kehl S, Pretscher J, Baier F, Bayer CM, Schwenke E, Schneider MO, Mayr A, Schild RL, Schmid M, Beckmann MW, Faschingbauer F: Correlation of short-term variation and Doppler parameters with adverse perinatal outcome in low-risk fetuses at term. 2019
Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Milne RL, Schmidt MK, Pharoah PDP, Andrulis IL, Hunter DJ, Simard J, Easton DF, Zheng W, Breast Cancer Association Consortium , Alicia BJ, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Auer PL, Barrdahl M, Baynes C, Beane Freeman LE, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Brinton L, Broberg P, Brucker SY, Brüning T, Burwinkel B, Cai Q, Caldes T, Canzian F, Carter BD, Castelao JE, Chang-Claude J, Chenevix-Trench G, David Cheng TY, Clarke CL, Conroy DM, Couch FJ, Cox DG, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Doheny KF, Dörk T, dos-Santos-Silva I, Dumont M, Dunning AM, Dwek M, Earp HS, Eccles DM, Heather Eliassen A, Engel C, Eriksson M, Gareth Evans D, Fachal L, Fasching PA, Figueroa J, Fletcher O, Flyger H, Fritschi L, Gabrielson M, Gago-Dominguez M, Gapstur SM, García-Closas M, Gaudet MM, Ghoussaini M, Giles GG, Goldberg MS, Goldgar DE, González-Neira A, Guénel P, Hahnen E, Haiman CA, Håkansson N, Hall P, Hallberg E, Hamann U, Harrington P, He W, Hein A, Hicks B, Hillemanns P, Hogervorst FB, Hollestelle A, Hoover RN, Hopper JL, Howell A, Huang G, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jung A, Kaaks R, Kabisch M, Kerin MJ, Khusnutdinova E, Kitahara CM, Kosma VM, Koutros S, Kraft P, Kristensen VN, Lambrechts D, Le Marchand L, Lindström S, Linet MS, Lissowska J, Loibl S, Lubinski J, Luccarini C, Lux MP, Maishman T, Kostovska IM, Mannermaa A, Manoukian S, Manson JE, Margolin S, Mavroudis D, Meijers-Heijboer H, Meindl A, Menon U, Meyer J, Mulligan AM, Neuhausen SL, Nevanlinna H, Neven P, Newman WT, Nielsen SF, Nordestgaard BG, Olopade OI, Olshan AF, Olson JE, Olsson H, Olswold C, Orr N, Perou CM, Peto J, Plaseska-Karanfilska D, Prentice R, Presneau N, Pylkäs K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Romero A, Romm J, Saloustros E, Sandler DP, Sawyer EJ, Schmutzler RK, Schneeweiss A, Scott RJ, Scott C, Seal S, Seynaeve C, Smeets A, Southey MC, Spinelli JJ, Stone J, Surowy H, Swerdlow AJ, Tamimi R, Tapper W, Taylor JA, Terry MB, Tessier DC, Thöne K, Tollenaar RAEM, Torres D, Troester MA, Truong T, Untch M, Vachon C, Van Den Berg D, van den Ouweland AMW, van Veen EM, Vincent D, Waisfisz Q, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Winqvist R, Wolk A, Xia L, Yang XR, Ziogas A, Ziv E: Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. 2019
Ruddy KJ, Schaid DJ, Partridge AH, Larson NB, Batzler A, Haeberle L, Dittrich R, Widschwendter P, Fink V, Bauer E, Schwitulla J, Ruebner M, Ekici AB, Aivazova-Fuchs V, Stewart EA, Beckmann MW, Ginsburg E, Wang LW, Weinshilboum RM, Couch FJ, Janni W, Rack B, Vachon C, Fasching PA: Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer. 2019
Scharl AJ, Beckmann MW: 257b Statement by the German Society for Gynaecology and Obstetrics e. V. (DGGG) on biomarker-based Tests to decide whether or not to use adjuvant systemic Chemotherapy for primary Breast Cancer 2019
Stumpfe FM, Faschingbauer F: Response to "Letter to the Editor" by Federico Prefumo. 2019
Beckmann MW: Dear Reader 2019
Lotz L, Dittrich R, Hoffmann I, Beckmann MW: Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy. 2019
Hartkopf AD, Brucker SY, Taran FA, Harbeck N, von Au A, Naume B, Pierga JY, Hoffmann O, Beckmann MW, Ryden L, Fehm T, Aft R, Montserrat S, Walter V, Rack B, Schuetz F, Borgen E, Ta MH, Bittner AK, Fasching P, Ferno M, Krawczyk N, Weilbaecher K, Margeli M, Hahn M, Jueckstock J, Domschke C, Bidard FC, Kasimir-Bauer S, Schoenfisch B, Kurt AG, Wallwiener M, Gebauer G, Wallwiener D, Janni W, Pantel K: International pooled analysis of the prognostic impact of disseminated tumor cells from the bone marrow in early breast cancer: Results from the PADDY study 2019

Direktlinks

Central Biobank Erlangen (CeBE)
Forschungsberichte